🔔Stock Alerts via Telegram — Free for All Users

NATR Stock Risk & Deep Value Analysis

Nature's Sunshine Products Inc

Consumer Defensive • Packaged Foods

DVR Score

0.3

out of 10

Distressed

What You Need to Know About NATR Stock

We analyzed Nature's Sunshine Products Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran NATR through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.

Updated Mar 24, 2026Run Fresh Analysis →

NATR Risk Analysis & Red Flags

Risk Matrix

Overall

Moderate

Financial

Low

Market

Medium

Competitive

Medium

Execution

Medium

Regulatory

Medium

Upcoming Risk Events

  • 📅

    Weaker-than-expected Q1 2026 earnings or revised guidance

  • 📅

    Increased competitive pressure in the direct-selling supplement market

  • 📅

    Regulatory scrutiny on direct-selling models or supplement claims

Unlock NATR Risk Analysis & Red Flags

Create a free account to see the full analysis

What Does Nature's Sunshine Products Inc (NATR) Do?

Market Cap

$474.13M

Sector

Consumer Defensive

Industry

Packaged Foods

Employees

819

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company provides general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; immune products; cardiovascular products; and digestive products. It also offers personal care products, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste, and skin cleanser products, as well as weight management products. The company provides its products under the Nature's Sunshine Products and Synergy WorldWide brands directly to customers and to a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

Visit Nature's Sunshine Products Inc Website

Investment Thesis

Nature's Sunshine Products (NATR) is a financially healthy company with improving operational metrics and strong insider confidence, making it a compelling candidate for stable, moderate growth within the health and wellness sector. Its debt-free balance sheet and consistent profitability provide a strong foundation, though its business model limits hyper-growth potential for 10x returns.

Is NATR Stock Undervalued?

Nature's Sunshine Products (NATR) shows improved financial health and positive recent momentum. The Q4 2025 earnings beat, 4.7% YoY revenue growth, and 16% YoY adjusted EBITDA growth are encouraging. Crucially, the CEO and CFO made significant share purchases prior to the earnings release, signaling strong insider confidence. The company boasts a robust balance sheet with $93.9M cash and zero debt, alongside positive operating cash flow and improving margins. However, the fundamental limitations of its direct-selling (MLM) model in a mature, fragmented nutritional supplements market still largely preclude a path to 10x growth within 3-5 years. While showing stability and steady growth, there's no evidence of disruptive innovation, a unique technological moat, or strategic pivots that could drive exponential market share capture. Therefore, despite positive operational performance, it does not fit the high-risk, high-reward 10x growth profile.

Unlock the full AI analysis for NATR

Get the complete DVR score, risk analysis, and more

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

NATR Price Targets & Strategy

12-Month Target

$30.00

Bull Case

$33.00

Bear Case

$20.00

Valuation Basis

Based on 25x estimated FY26 EPS of $1.20 = $30.00

Entry Strategy

Consider dollar-cost averaging on dips towards $22-$23, capitalizing on recent positive momentum and insider buys.

Exit Strategy

Take profit at target levels of $30-$33; implement a stop loss at $20 to protect capital against market downturns or unexpected news.

Portfolio Allocation

2% for moderate risk tolerance

Price Targets & Strategy

Upgrade to Premium for price targets and entry/exit strategies

Is NATR Financially Healthy?

Valuation

P/E Ratio

33.71

Forward P/E

29.30

EV/EBITDA

9.58

PEG Ratio

2.50

Price/Book

2.57

Price/Sales

0.99

Profitability

Gross Margin

52.00%

Operating Margin

4.30%

Net Margin

4.10%

Return on Equity

10.19%

Revenue Growth

5.70%

EPS

$0.80

Balance Sheet

Current Ratio

2.27

Quick Ratio

1.35

Debt/Equity

0.15

Total Debt

$15.00M

Cash & Equivalents

$45.00M

Cash Flow

Operating Cash Flow

$35.32M

Free Cash Flow

$20.00M

EBITDA

$49.40M

Other

Beta (Volatility)

0.87

Does NATR Have a Competitive Moat?

Sign in to unlock

Moat Rating

🛡️ Narrow

Moat Trend

Stable

Moat Sources

3 Identified

Brand PowerSwitching Costs (for dedicated distributors and long-term customers)Efficient Scale (established manufacturing and distribution infrastructure)

NATR's moat is primarily driven by its established brand in the nutritional supplements space and the inherent stickiness of a direct-selling network. This provides a loyal customer base and a distribution channel that is difficult to replicate quickly. However, it's not immune to competition or changing consumer preferences.

Moat Erosion Risks

  • Emergence of new, disruptive direct-to-consumer health brands with lower overheads
  • Shifting consumer sentiment away from direct-selling models towards e-commerce
  • Intense competition in a crowded supplement market

NATR Competitive Moat Analysis

Sign up to see competitive advantages

NATR Market Intelligence

Sentiment & Insider Activity

Social Sentiment

Neutral (no specific data provided)

Institutional Sentiment

Positive (Institutional ownership 79.40%–83.62%, recent analyst upgrades by DA Davidson and Canaccord Genuity)

Insider Activity (Form 4)

CEO Kenneth G. Romanzi bought 29,928 shares ($750k) on 2026-03-06. CFO Leslie Shane Jones net bought 10,920 shares ($273.66k) on 2026-03-06. EVP Bryant J. Yates bought 7,761 shares ($194.49k) on 2026-03-06 but sold 15,383 shares ($377k) on 2026-03-17. SVP Jonathan David Lanoy sold 4,000 shares ($98.8k) on 2026-03-13. Net buys by key executives (CEO/CFO) before earnings are a strong positive signal.

Options Flow

Normal options activity (no specific data provided)

Earnings Intelligence

Next Earnings

Estimated early-May 2026

Surprise Probability

Medium

Historical Earnings Pattern

Q4 2025 earnings beat estimates, leading to analyst price target increases. The stock may show positive reaction to beats and negative reaction to misses or weak guidance.

Key Metrics to Watch

Revenue growth rate (YoY and sequential)Adjusted EBITDA performance relative to guidanceGross and operating margin trends2026 full-year guidance updates

Competitive Position

Top Competitor

Not specified in real-time market intelligence. General competitors include other direct-selling nutrition companies.

Market Share Trend

Stable (no specific data provided to indicate significant gains or losses)

Valuation vs Peers

Cannot accurately assess without specific peer valuation metrics; trailing P/E of 23.4–31.58 appears reasonable for a company with stable growth and strong profitability.

Competitive Advantages

  • Established brand recognition within its direct-selling network
  • Loyal distributor and customer base for nutritional products
  • Debt-free balance sheet provides financial flexibility

Market Intelligence

Get sentiment, earnings intel, and peer analysis with Premium

What Could Drive NATR Stock Higher?

Near-Term (0-6 months)

  • Q1 2026 Earnings Report (Expected early-May 2026)
  • Continued execution on 2026 full-year guidance (Revenue $500–$515M, Adj. EBITDA $50–$54M)

Medium-Term (6-18 months)

  • Potential for further share buybacks, enhancing shareholder value
  • Improved leverage of direct sales network effectiveness and distributor engagement

Long-Term (18+ months)

  • Potential for gradual market share gains in fragmented health & wellness sector
  • Strategic expansions into new product categories or international markets (if announced)

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for NATR?

  • Sustained acceleration in organic revenue growth above 5-7% year-over-year

  • Continued expansion of gross and operating margins, indicating operational efficiency

  • Announcement of strategic partnerships or market-expanding initiatives

Bull Case Analysis

See what could go right with Premium

Competing with NATR

See how Nature's Sunshine Products Inc compares to related companies

CompanyMarket CapDVR ScoreP/ERevenueProfit MarginRev Growth

Nature's Sunshine Products Inc

NATR

$474.1M0.333.7$480.1M4.1%5.7%

Costco Wholesale Corp

COST

0.7Compare →

Coca-Cola Co

KO

$324.9T0.43.1$47.9B27.3%1.9%Compare →

PepsiCo Inc

PEP

0.1Compare →

Procter & Gamble Co

PG

0.2Compare →

Walmart Inc

WMT

$1.0T0.747.4$713.2B3.1%4.7%Compare →

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

FAQ

What is the DVR Score for Nature's Sunshine Products Inc (NATR)?

As of March 24, 2026, Nature's Sunshine Products Inc has a DVR Score of 0.3 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Nature's Sunshine Products Inc?

Nature's Sunshine Products Inc's market capitalization is approximately $474.1M. The company operates in the Consumer Defensive sector within the Packaged Foods industry.

What ticker symbol does Nature's Sunshine Products Inc use?

NATR is the ticker symbol for Nature's Sunshine Products Inc. The company trades on the NCM.

What is the risk level for NATR stock?

Our analysis rates Nature's Sunshine Products Inc's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of NATR?

Nature's Sunshine Products Inc currently has a price-to-earnings (P/E) ratio of 33.7. This is above the market average, suggesting the stock may be priced for high growth expectations.

Is Nature's Sunshine Products Inc's revenue growing?

Nature's Sunshine Products Inc has reported revenue growth of 5.7%. The company is growing at a moderate pace.

Is NATR stock profitable?

Nature's Sunshine Products Inc has a profit margin of 4.1%. The company is profitable but margins are modest.

How often is the NATR DVR analysis updated?

Our AI-powered analysis of Nature's Sunshine Products Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 24, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for NATR (Nature's Sunshine Products Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

Navigated to NATR Stock Risk & Deep Value Analysis